News & Articles
Category: As Seen In
Robert Bowser, PhD on TDP-43’s Role in ALS
Robert Bowser, PhD, recaps his ALS Nexus presentation on TDP-43 biology, the emerging therapeutic landscape, and how cryptic peptide biomarkers could reshape ALS clinical trial design.
Barrow Awarded $5M for Ibogaine Clinical Trial in TBI
Barrow Neurological Institute has received a $5 million grant from the Arizona Department of Health Services to study ibogaine treatment in people with neurological disorders such as traumatic brain injury (TBI).
Barrow, ASU Embark on One of First Clinical Trials of Ibogaine in the US
For people living with post-traumatic stress disorder, depression or addiction, existing treatments do not always bring relief. Some are desperate enough to travel outside the United States for...
Nationwide Association Between Proximity to Dry Cleaners and Risk of Parkinson’s Disease
Environmental trichloroethylene (TCE) exposure from dry cleaners represents a potentially remediable risk factor for Parkinson’s disease (PD).
Human Bodies Don’t Read Textbooks: Beyond Heuristics
Dr. Ayushi Chugh discusses how patients with neurological disorders often present with distinct extrinsic clinical phenomenology.